NCT01570907View on ClinicalTrials.gov

Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Treatment for Bipolar I Disorder
Interventions
DRUG

Quetiapine Fumarate

25 mg tablet

Trial Locations (1)

77042

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT01570907 - Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions | Biotech Hunter | Biotech Hunter